SARS-CoV-2 needs cholesterol to invade cells and form mega cells
On Jan. 25, 2021, HHMI investigators reported that cholesterol, the waxy compound better known for clogging arteries, helps…
PRINCIPLE found antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19
On Jan. 25, 2021, scientists at the University of Oxford reported that after reviewing interim analyses of both…
Humanigen and Emergent BioSolutions announced CDMA for phase 3 COVID-19 therapeutic candidate Lenzilumabï¾™
On Jan. 25, 2021, Emergent BioSolutions and Humanigen announced a contract development and manufacturing (CDMO) services agreement to…
Nirmidas Biotech received FDA Emergency Use Authorization for its COVID-19 rapid antibody fingerstick test
On Jan. 25, 2021, Nirmidas Biotech announced its second FDA Emergency Use Authorization (EUA) for their COVID-19 rapid…
Full-dose blood thinners decreased need for life support and improved outcome in COVID-19 patients
On Jan. 22, 2021, the NIH announced that in large clinical trial conducted worldwide, full dose anti-coagulation (blood…
COVAX announced new agreement, plans for first deliveries
On Jan. 22, 2021, COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for…
Pfizer and BioNTech reached agreement with COVAX for advance purchase of vaccine to combat COVID-19
On Jan. 22, 2021, Pfizer and BioNTech announced an advance purchase agreement with COVAX for up to 40…
NIH researchers identified new genetic disorder that affects brain, craniofacial skeleton
On Jan. 21, 2021, researchers at the NIH announced they had discovered a new genetic disorder characterized by…
NIH study compares low-fat, plant-based diet to low-carb, animal-based diet
On Jan. 21, 2021, the National Institutes of Health announced results of a small but highly controlled study…
FDA approved first extended-release, injectable drug regimen for adults living with HIV
On Jan. 21, 2021, the FDA approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for…
The US Department of Defense recommended adults 75 and older should seek COVID-19 vaccine
On Jan. 21, 2021, the U.S. Department of Defense (DOD) recommended that adults ages 75 and older should…
A closer look at T cells revealed big differences in mild vs severe COVID-19 cases
On Jan. 21, 2021, NIH researchers announced that after people recover from infection with a virus, the immune…
Lilly’s neutralizing antibody bamlanivimab (LY-CoV555) prevented COVID-19 at nursing homes in the BLAZE-2 trial
On Jan. 21, 2021, Eli Lilly announced that bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19…
VBI Vaccines announced progress of Coronavirus vaccine program
On Jan. 21, 2021, VBI Vaccines announced that it expected to initiate the first Phase 1/2 clinical study…
Janssen announced FDA approval of CABENUVA, the first long-acting HIV treatment regimen
On Jan. 21, 2021, Janssen Pharmaceutical announced the FDA had approved CABENUVA (consisting of Janssenï¾’s rilpivirine and ViiV…
Patients in cancer remission at high risk for severe COVID-19 illness
On Jan. 21, 2021, Penn Medicine reported that patients with inactive cancer and not currently undergoing treatments also…
XBiotech candidate True Humanï¾™ COVID-19 therapy found to target highly infectious emerging strain
On Jan. 21, 2021, XBiotech announced that its COVID-19 candidate True Humanï¾™ antibody therapy may also be used…
INEOS donated ï¾£100 million to create new Oxford University institute to fight antimicrobial resistance
On Jan. 19, 2021, a new state of the art institute for antimicrobial research iwasa announced at Oxford…
TGen-NAU study results showed COVID-19 virus triggers antibodies from previous coronavirus infections
On Jan. 19, 2021, the Northern Arizona University and TGen, an affiliate of City of Hope, announced results…
ImmunityBio simulations revealed why spreading South Africa strain of SARS-CoV-2 may escape existing immunity
On Jan. 19, 2021, ImmunityBio reported findings from a follow-up Molecular Dynamics simulation study of the SARS-CoV-2 spike…
ImmunityBio announced phase I trial of COVID-19 vaccine candidate in South Africa as new variants spread
On Jan. 19, 2021, ImmunityBio announced it had received authorization from the South Africa Health Products Regulatory Authority…
Mesa Biotech received 510(k) clearance and CLIA waiver for Its Accula Strep A Molecular Point of Care Test
On Jan. 19, 2021, Mesa Biotech announced it had received 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA)…
Heat Biologics commenced manufacturing process for ZVX-60
On Jan. 19, 2021, Heat Biologics announced it had transferred its gp96-based COVID-19 vaccine cell line (“ZVX-60”) to…
Pfizer and BioNTech published results of study showing COVID-19 vaccine antibodies neutralized UK strain
On Jan. 19, 2021, Pfizer and BioNTech announced that results from an in vitro study that provided additional…
Sequenced genome of the Australian lungfish 14x larger than human genome
On Jan, 18, 2021, researchers in Konstanz, Wurzburg, Hamburg and Vienna, led by evolutionary biologist Professor Axel Meyer…
Quest Diagnostics granted CDC contract to sequence COVID-19 gene variants to aid public health response
On Jan. 18, 2021, Quest Diagnostics announced that it has entered into an agreement with the Centers for…
NIAID microbiota study iIdentified nutrient that help prevent bacterial infection
On Jan. 15, 2021, scientists studying the bodyï¾’s natural defenses against bacterial infection announced they had identified a…
RECOVERY trial closed recruitment to convalescent plasma treatment for patients hospitalised with COVID-19
On Jan. 15, 2021, Oxford University announced that on advice of the independent Data Monitoring Committee (DMC), recruitment…
VBI Vaccines announced publication of results from phase 4 study of prophylactic 3-ntigen HBV in vaccine
On Jan. 15, 2021, VBI Vaccines announced that results from a Phase 4 study of VBIï¾’s prophylactic 3-antigen…
Pfizer and BioNTech announced European scale-up of manufacturing capacities
On Jan. 15, 2021, Pfizer and BioNTech announced they had developed a plan that allowed the scale-up of…